Stock Events

Stock Events

Genus 

GBX2,570
20
+GBX2+0.08% Today

Statistics

Day High
2,584
Day Low
2,550
52W High
3,170
52W Low
1,586
Volume
362,482.84
Avg. Volume
-
Mkt Cap
0
P/E Ratio
36.45
Dividend Yield
1.26%
Dividend
32.31

Upcoming

9
NOV
Dividend Ex
Estimated
 
4
DEC
Dividend Payment
Estimated
 
8
MAR 27
Dividend Ex
Estimated
 
26
MAR 27
Dividend Payment
Estimated
 
8
NOV 27
Dividend Ex
Estimated
 

Dividends

1.26%Dividend Yield
Mar 26
GBX11.2
Dec 25
GBX21.7
Apr 25
GBX10.3
Dec 24
GBX21.7
Mar 24
GBX10.3
10Y Growth
4.25%
5Y Growth
0%
3Y Growth
3.95%
1Y Growth
4.09%

Earnings

26FebExpected
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
0
19.98
39.95
59.93
Expected EPS
N/A
Actual EPS
59.92803648

Financials

2.87%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
134.56BRevenue
3.86BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GNS.LSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zoetis
ZTS
Mkt Cap51.66B
Zoetis is a global animal health company that offers products and services for livestock, which competes directly with Genus's offerings in animal genetics and health.
Elanco Animal Health
ELAN
Mkt Cap11.83B
Elanco Animal Health provides a range of products for animal health and welfare, competing in the same market as Genus, particularly in the livestock sector.
Idexx Laboratories
IDXX
Mkt Cap46.92B
IDEXX Laboratories specializes in diagnostics and healthcare for animals, competing with Genus in the broader animal health market.
Abbott Laboratories
ABT
Mkt Cap168.23B
Abbott Laboratories, through its animal health division, competes with Genus in providing products for livestock health and productivity.
Phibro Animal Health
PAHC
Mkt Cap2.29B
Phibro Animal Health Corporation offers animal health and nutritional products for livestock, directly competing with Genus in the animal health sector.
Vir Biotechnology
VIR
Mkt Cap1.73B
Virbac provides veterinary products and services, competing with Genus in the global animal health market, especially in the care and productivity of livestock.
BWX Technologies
BWXT
Mkt Cap21.6B
BWX Technologies, though primarily focused on nuclear technology, has divisions that could overlap with biotechnological advancements in animal genetics, representing a potential indirect competitor to Genus in innovative animal health solutions.

About

Genus plc produces and sells animal genetics to farmers in North America, Latin America, the United Kingdom, the rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It offers dairy and beef bull semen and embryos under the Genus and Bovec brands; breeding pork and semen, as well as technical services and advice under the PIC brand. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.
Show more...
CEO
Mr. Jorgen Kokke
Employees
3190
Country
United Kingdom
ISIN
GB0002074580

Listings

STU
DE
GBE.STU
OTC Link
US
GENSY
F
DE
GBE.F
OTC Link
US
GENSF

0 Comments

Share your thoughts

FAQ

What is Genus stock price today?▼
The current price of GNS.LSE is GBX2,570 GBX — it has increased by +0.08% in the past 24 hours. Watch Genus stock price performance more closely on the chart.
What is Genus stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Genus stocks are traded under the ticker GNS.LSE.
Is Genus stock price growing?▼
GNS.LSE stock has fallen by -3.31% compared to the previous week, the month change is a +0.59% rise, over the last year Genus has showed a +60.02% increase.
When is the next Genus earnings date?▼
Genus is going to release the next earnings report on September 10, 2026.
What were Genus earnings last quarter?▼
GNS.LSE earnings for the last quarter are 59.93 GBX per share, whereas the estimation was N/A GBX resulting in a N/A surprise. The estimated earnings for the next quarter are N/A GBX per share.
What is Genus revenue for the last year?▼
Genus revenue for the last year amounts to 134.56B GBX.
What is Genus net income for the last year?▼
GNS.LSE net income for the last year is 3.86B GBX.
Does Genus pay dividends?▼
Yes, GNS.LSE dividends are paid semi-annual. The last dividend per share was 11.2 GBX. As of today, Dividend Yield (FWD)% is 1.26%.
How many employees does Genus have?▼
As of April 22, 2026, the company has 3,190 employees.
In which sector is Genus located?▼
Genus operates in the Health & Wellness sector.
When did Genus complete a stock split?▼
Genus has not had any recent stock splits.
Where is Genus headquartered?▼
Genus is headquartered in Basingstoke, United Kingdom.